Acute leukemia in children with Down syndrome
- PMID: 20595099
- PMCID: PMC2895024
- DOI: 10.3324/haematol.2010.024968
Acute leukemia in children with Down syndrome
Similar articles
-
Should we treat children with Down syndrome and leukemia in the developing world?Pediatr Hematol Oncol. 2012 Mar;29(2):105-8. doi: 10.3109/08880018.2011.652341. Pediatr Hematol Oncol. 2012. PMID: 22376013 No abstract available.
-
Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.J Pediatr Hematol Oncol. 2016 May;38(4):283-7. doi: 10.1097/MPH.0000000000000540. J Pediatr Hematol Oncol. 2016. PMID: 26907658 Free PMC article. Review.
-
Cytogenetic studies in children with Down syndrome and acute leukemia.Leuk Res. 2005 Nov;29(11):1241-6. doi: 10.1016/j.leukres.2005.03.015. Epub 2005 Apr 25. Leuk Res. 2005. PMID: 16164980
-
Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.Haematologica. 2010 Jul;95(7):1106-13. doi: 10.3324/haematol.2009.019778. Epub 2010 Apr 23. Haematologica. 2010. PMID: 20418240 Free PMC article.
-
Down syndrome and leukemia--an overview of cytogenetic and molecular events.Turk J Pediatr. 1997 Oct-Dec;39(4):519-31. Turk J Pediatr. 1997. PMID: 9433155 Review. No abstract available.
Cited by
-
Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology.Mol Ther Methods Clin Dev. 2020 Sep 16;19:201-209. doi: 10.1016/j.omtm.2020.09.007. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 33102613 Free PMC article.
-
Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21.Cells. 2022 Feb 11;11(4):628. doi: 10.3390/cells11040628. Cells. 2022. PMID: 35203280 Free PMC article.
-
Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex.Blood Adv. 2017 Sep 8;1(20):1717-1728. doi: 10.1182/bloodadvances.2017006023. eCollection 2017 Sep 12. Blood Adv. 2017. PMID: 29296818 Free PMC article.
-
Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.PLoS One. 2017 Apr 21;12(4):e0175701. doi: 10.1371/journal.pone.0175701. eCollection 2017. PLoS One. 2017. PMID: 28430788 Free PMC article.
-
Genetics of blood malignancies among Iranian population: an overview.Diagn Pathol. 2020 May 6;15(1):44. doi: 10.1186/s13000-020-00968-2. Diagn Pathol. 2020. PMID: 32375828 Free PMC article. Review.
References
-
- Cannon HE. Acute lymphatic leukemia: report of a case in an eleventh month Mongolian idiot. New Orleans Med Surg J. 1930;94(3):289–93.
-
- Ravindranath Y, Abella E, Krischer JP, Wiley J, Inoue S, Harris M, et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood. 1992;80(9):2210–4. - PubMed
-
- Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, et al. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children’s Cancer Group studies 2861 and 2891. Blood. 1998;91(2):608–15. - PubMed
-
- Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J, et al. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol. 2005;128(6):797–804. - PubMed
-
- Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia. 2005;19(8):1355–60. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical